Cancer

Diseases, Conditions, Syndromes

Tyrosine kinase inhibitors seem safe in CML with CKD

(HealthDay)—Tyrosine kinase inhibitors (TKIs) appear to be safe in patients with chronic-phase (CP) chronic myeloid leukemia (CML) and chronic kidney disease (CKD), according to a study published online July 28 in Cancer.

page 5 from 40